ABT vs EAF
Abbott Laboratories (ABT) versus GrafTech International Ltd (EAF) — a side-by-side from cached financials, not a winner call.
Abbott Laboratories (ABT) is a medical devices company listed on NYSE.
GrafTech International Ltd (EAF) is a electrical equipment & parts company listed on US.
Latest reported ABT revenue for 2025-12-31 was $44.33B. Net income was $6.52B. Revenue was up 5.7% from 2024-12-31 to 2025-12-31. ABT currently screens at market cap $154.15B and trailing P/E 24.8.
Latest reported EAF revenue for 2024-12-31 was $538.8M. Net income was -$131.2M. Revenue was down 13.2% from 2023-12-31 to 2024-12-31. EAF currently screens at market cap $245.6M.
ABT currently screens at market cap $154.15B and trailing P/E 24.8. EAF currently screens at market cap $245.6M.
Not investment advice. Open the ABT and EAF stock pages for the full models.
Not investment advice.